Roles of alternatively activated M2 macrophages in allergic contact dermatitis

Allergology International

Volumn 66, Issue 3, 2017, Pages 392-397

  Suzuki, Kotaro ^a   Meguro, Kazuyuki ^a   Nakagomi, Daiki ^b   Nakajima, Hiroshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Contact hypersensitivity; M2 macrophages; mannose receptor; MMP12; SOCS3

Indexed keywords

HAPTEN; MACROPHAGE ELASTASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; 1 FLUORO 2,4 DINITROBENZENE; AUTACOID; CYTOKINE;

CELL PLASTICITY; CELLULAR DISTRIBUTION; CONTACT ALLERGY; CYTOKINE PRODUCTION; MACROPHAGE ACTIVATION; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKIN ALLERGY; ANIMAL; CHRONIC DISEASE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; PATHOLOGY;

ANIMALS; CHRONIC DISEASE; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; DINITROFLUOROBENZENE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGE ACTIVATION; MACROPHAGES; MATRIX METALLOPROTEINASE 12; SUPPRESSOR OF CYTOKINE SIGNALING 3 PROTEIN;

EID: 85015360020     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.1016/j.alit.2017.02.015     Document Type: Review

References (34)

1. Usatine, R.P., Riojas, M., Diagnosis and management of contact dermatitis. Am Fam Physician 82 (2010), 249–255.
2. Martin, S.F., Esser, P.R., Weber, F.C., Jakob, T., Freudenberg, M.A., Schmidt, M., et al. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 66 (2011), 1152–1163.
3. Kaplan, D.H., Igyarto, B.Z., Gaspari, A.A., Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 12 (2012), 114–124.
4. Honda, T., Egawa, G., Grabbe, S., Kabashima, K., Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol 133 (2012), 303–315.
5. Kabashima, K., Sakata, D., Nagamachi, M., Miyachi, Y., Inaba, K., Narumiya, S., Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 9 (2003), 744–749.
6. Kaplan, D.H., In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol 31 (2010), 446–451.
7. Mori, T., Kabashima, K., Yoshiki, R., Sugita, K., Shiraishi, N., Onoue, A., et al. Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated Langerhans cell Th2 chemokines. J Invest Dermatol 128 (2008), 1719–1727.
8. Honda, T., Matsuoka, T., Ueta, M., Kabashima, K., Miyachi, Y., Narumiya, S., Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity. J Allergy Clin Immunol 124 (2009), 809–818.
9. Weaver, C.T., Hatton, R.D., Mangan, P.R., Harrington, L.E., IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25 (2007), 821–852.
10. He, D., Wu, L., Kim, H.K., Li, H., Elmets, C.A., Xu, H., IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses. J Immunol 183 (2009), 1462–1470.
11. Kelly, M., Hwang, J.M., Kubes, P., Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol 120 (2007), 3–10.
12. Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122 (2012), 787–795.
13. Gordon, S., Martinez, F., Alternative activation of macrophages: mechanism and functions. Immunity 32 (2010), 593–604.
14. Colin, S., Chinetti-Gbaguidi, G., Staels, B., Macrophage phenotypes in atherosclerosis. Immunol Rev 262 (2014), 153–166.
15. Stein, M., Keshav, S., Harris, N., Gordon, S., Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176 (1992), 287–292.
16. Jetten, N., Verbruggen, S., Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 1 (2014), 109–118.
17. Dyken, S.J., Locksley, R.M., Interleukin-4- and Interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 31 (2013), 317–343.
18. Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8 (2008), 958–969.
19. Mosser, D.M., The many faces of macrophage activation. J Leukoc Biol 73 (2003), 209–212.
20. Nakagomi, D., Suzuki, K., Meguro, K., Hosokawa, J., Tamachi, T., Takatori, T., et al. Matrix metalloproteinase 12 is produced by M2 macrophages and plays important roles in the development of contact hypersensitivity. J Allergy Clin Immunol 135 (2015), 1397–1400.
21. Hartmann, B., Staedtler, F., Hartmann, N., Meingassner, J., Firat, H., Gene expression profiling of skin and draining lymph nodes of rats affected with cutaneous contact hypersensitivity. Inflamm Res 55 (2006), 322–334.
22. Khokha, R., Murthy, A., Weiss, A., Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol 13 (2013), 649–665.
23. Hautamaki, R.D., Kobayashi, D.K., Senior, R.M., Shapiro, S.D., Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277 (1997), 2002–2004.
24. Senior, R.M., Griffin, G.L., Mecham, R.P., Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest 66 (1982), 859–862.
25. Dean, R.A., Cox, J.H., Bellac, C.L., Doucet, A., Starr, A.E., Overall, C.M., Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 112 (2008), 3455–3464.
26. Nénan, S., Boichot, E., Planquois, J.M., Berna, P., Hitier, S., Bénard, T., et al. Effects of depletion of neutrophils or macrophages on the inflammatory response induced by metalloelastase (MMP-12) in mice airways. Eur J Pharmacol 579 (2008), 374–381.
27. W1, Li, Li, J., Wu, Y., Wu, J., Hotchandani, R., Cunningham, K., et al. A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408). J Med Chem 26 (2009), 421–452.
28. Klose, A., Zigrino, P., Mauch, C., Monocyte/macrophage MMP-14 modulates cell infiltration and T-cell attraction in contact dermatitis but not in murine wound healing. Am J Pathol 182 (2013), 755–764.
29. Yoshimura, A., Suzuki, M., Sakaguchi, R., Hanada, T., Yasukawa, H., SOCS, inflammation, and autoimmunity. Front Immunol, 3, 2012, 20.
30. Linossi, E.M., Babon, J.J., Hilton, D.J., Nicholson, S.E., Suppression of cytokine signaling: the SOCS perspective. Cytokine Growth Factor Rev 24 (2013), 241–248.
31. Qin, H., Holdbrooks, A.T., Liu, Y., Reynolds, S.L., Yanagisawa, L.L., Benveniste, E.N., SOCS3 deficiency promotes M1 macrophage polarization and inflammation. J Immunol 189 (2012), 3439–3448.
32. Liu, Y., Stewart, K.N., Bishop, E., Marek, C.J., Kluth, D.C., Rees, A.J., et al. Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo. J Immunol 180 (2008), 6270–6278.
33. Meguro, K., Nakagomi, D., Suzuki, K., Hosokawa, J., Fukuta, T., Yokota, M., et al. SOCS3 expressed in M2 macrophages attenuates contact hypersensitivity by suppressing MMP-12 production. J Invest Dermatol 136 (2016), 649–657.
34. Yan, C., Ward, P.A., Wang, X., Gao, H., Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway. FASEB J 27 (2013), 2967–2976.